GlassScriptPhysician profile
Linda Yu
NPI 1164624052
$18,906.36
in general payments reported to CMS, 2019-2025
32 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $158 · 2021: $339 · 2022: $835 · 2023: $658 · 2024: $6,095 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $2,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,400.00 |
| Food and Beverage | $2,042.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $15,400.00 | 2024-2025 | Bovine Collagen |
| Astellas Pharma US INC | $486.15 | 2020-2025 | Veozah |
| Sumitomo Pharma America, INC. | $380.77 | 2023-2025 | Myfembree |
| Sage Therapeutics, LLC | $304.66 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $299.05 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Myovant Sciences INC. | $221.92 | 2021-2022 | |
| Daiichi Sankyo INC. | $197.43 | 2020-2024 | Injectafer |
| Aspira Women'S Health INC | $167.55 | 2022 | |
| Mayne Pharma Commercial LLC | $158.46 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $129.58 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $124.91 | 2019-2024 | Gardasil 9, Gardasil |
| Myriad Women'S Health, INC. | $104.50 | 2023 | |
| Axonics, INC. | $99.49 | 2024 | Bulkamid, Axonics |
| Pfizer INC. | $94.95 | 2024-2025 | |
| Therapeuticsmd, INC. | $86.12 | 2019-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $73.31 | 2022 | |
| Exeltis, USA INC. | $69.51 | 2020-2025 | Slynd |
| Organon LLC | $66.82 | 2021-2024 | |
| Evofem Biosciences, INC. | $53.54 | 2020-2022 | |
| Sanofi Pasteur INC. | $53.53 | 2025 | |
| Hologic Sales and Service, LLC | $53.21 | 2021-2025 | Myosure Tissue Removal Device |
| Shield Therapeutics INC | $52.52 | 2023-2025 | Accrufer |
| Supernus Pharmaceuticals, INC. | $52.09 | 2025 | Qelbree |
| Scynexis, INC. | $32.54 | 2022 | |
| Smith+Nephew, INC. | $27.61 | 2021-2025 | Pico |
| Novo Nordisk INC | $25.80 | 2025 | |
| Agile Therapeutics, INC. | $24.25 | 2022 | |
| Coopersurgical, INC. | $15.61 | 2023 | Summit Doppler |
| Avion Pharmaceuticals | $14.61 | 2022 | |
| Amgen INC. | $13.64 | 2025 | Evenity, Prolia |
| Lupin INC. | $11.23 | 2020 | |
| Amag Pharmaceuticals, INC. | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.